Navigation Links
AcelRx Pharmaceuticals Reports First Quarter 2011 Financial Results
Date:5/12/2011

ess of manufacturing components for the ARX-01 device.  We have selected the CRO to conduct the Phase 3 studies for ARX-01, and anticipate initiating enrollment in our first Phase 3 study, an efficacy study in major abdominal surgery, in the second half of 2011.  We anticipate initiating enrollment for our second Phase 3 study, a head-to-head comparison of ARX-01 to the standard of care, IV PCA morphine, in early 2012."

"We continue to believe that ARX-01 could become the treatment of choice for patient-controlled management of moderate-to-severe post-operative pain," said Mr. King.

Financial OutlookAcelRx anticipates that research and development expenses will increase over the next several years as it seeks to complete Phase 3 development of ARX-01.  AcelRx does not intend to initiate the third ARX-01 Phase 3 study, an efficacy study in orthopedic hip and knee replacement surgeries until additional funding is obtained.  The development of ARX-02,a product candidate for the treatment of cancer breakthrough pain, and ARX-03, a product candidate for mild sedation and pain relief in procedures conducted in a physician's office, will not advance until additional funding or the identification of a partner to support this effort is secured. Additionally, AcelRx anticipates increases in general and administrative expenses due to costs associated with operating as a public company and expansion of its corporate infrastructure to support ongoing development of its product candidates.

AcelRx believes its current cash and cash equivalents, and the interest earned thereon, are sufficient to fund operations through the second quarter of 2012.

About AcelRx Pharmaceuticals, Inc. Based in Redwood City, CA, AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX) is a specialty pharmaceutical company focused on the development and commercialization of innovati
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. AcelRx European Patent Covering its NanoTab® Sublingual Delivery Technology for Acute and Breakthrough Pain Pipeline Products Emerges From Opposition Period
2. AcelRx Pharmaceuticals to Present at the JMP Securities Research Conference
3. AcelRx Pharmaceuticals Reports Fourth Quarter and Full-Year 2010 Financial Results
4. AcelRx Pharmaceuticals to Present at the Cowen and Company 31st Annual Health Care Conference
5. AcelRx Pharmaceuticals Announces Pricing of Its Initial Public Offering
6. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
7. AcelRx Announces Positive Phase 2 Results From a Study of ARX-02 Sufentanil NanoTab(TM) Breakthrough Pain Management System in Treating Cancer Breakthrough Pain
8. AcelRx to Present at the Lazard 6th Annual Healthcare Conference
9. AcelRx Programs to be Featured in Oral Presentations at the American Society of Anesthesiologists 2009 Annual Meeting
10. AcelRx Announces Positive Phase 2 Results from a Study of ARX-01 Sufentanil NanoTabs in Treating Post-Operative Pain
11. AcelRx Initiates a Phase 2 Study to Evaluate Functionality of Its ARX-01 Sufentanil NanoTab PCA System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)...  Decision Resources Group finds that the Asia Pacific ... China , India , ... through 2023. Dental implant procedure volumes will grow as physicians are ... Other key findings from Decision Resources Group,s coverage of the ... , Dental implant penetration: Penetration of dental implants among the ...
(Date:9/30/2014)... 2014 A study using a relatively new ... look at the composition of carotid artery disease and ... treat the disease, a leading cause of stroke. ... between September 2010 and May 2012, was featured in ... the American College of Cardiology (JACC) Cardiovascular Interventions. ...
(Date:9/30/2014)... BEACH, Calif. , Sept. 30, 2014 /PRNewswire-USNewswire/ ... accreditation of the American Association of Tissue Banks ... Cook , Chief Executive Officer. Accreditation ... inspection by a specially trained AATB inspector.  It ... administrative performance within the facility meets or exceeds ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3New Imaging Tool May Allow Tailoring of Stroke Prevention to Each Patient 2Biostructures, LLC Earns AATB Accreditation 2
... Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ... researching, developing, manufacturing and marketing,biopharmaceutical products, today announced the ... October 12, 2009. , At ... and Mr.,Moujia Qi to serve as members of the ...
... used to treat high blood pressure appear to be effective ... stable ischemic heart disease, according to a new comparative effectiveness ... A version of the analysis was posted in the ... Medicine . , Treatment featuring the two medications -- inhibitors ...
Cached Medicine Technology:High Blood Pressure Medicines Show Promise For Treating Heart Disease 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 3
(Date:9/30/2014)... 2014 (HealthDay News) -- Sleep apnea is a potential health ... to a possible culprit behind the disorder: a "fat" tongue. ... deposits are increased in the tongue of obese patients with ... of the Sleep Center at the University of Pennsylvania Medical ... which will publish the findings Oct. 1. Sleep apnea ...
(Date:9/30/2014)... SILVERTHORNE, CO September 30, 2014 Keystone Symposia ... and the first in its 2014-15 Global Health Series ... at the Sheraton Seattle Hotel immediately following the ... grantees. The four-day conference is part of the Keystone ... Melinda Gates Foundation, which has also funded travel awards ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Dynamic ... have hampered growth in the Bread Production industry ... caused consumers to moderate their consumption of a ... for premium varieties shrunk the market for white ... operators proactively responded by introducing more nutritious products ...
(Date:9/30/2014)... Research by UC Irvine immunologists reveals new information ... a vital process that determines how the body,s ability ... of Nature Immunology , neurology professor Dr. Michael ... Immunology colleagues describe a critical mechanism underlying how T ... , A T cell is a type of blood ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Glycodrive ... Star Nutraceuticals designed to help maximize lean, strong muscle ... the body’s absorption of glucose has caught the attention ... “The main purpose behind Glycodrive is to help the ... muscle,” reports Michaels. “Carbs are essential in the muscle-building ...
Breaking Medicine News(10 mins):Health News:Could a 'Fat Tongue' Be a Factor in Sleep Apnea? 2Health News:Keystone Symposia launches 2014-2015 meeting series with Global Health Vaccines Conference 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Bread Production in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:UCI study uncovers important process for immune system development 2Health News:Glycodrive Review Exposes Blue Star Nutraceutical’s Supplement for Leaner, Stronger Muscles 2
... One-fourth of overweight children may have sleep problems that ... ,Research published in the November issue of Obesity ... children tested positive for sleep-disordered breathing, including telltale snoring. ... after-school physical activity such as jumping rope, basketball and ...
... a dearth of specialists, which was confirmed by the Hospital ... the hospital will have to put up with the shortfall ... services is currently on leave. The hospital is in the ... , ,The medical board is also ...
... and cynical exploitation” by the alternative medicines industry, argues a ... estimated that up to 80% of all patients with cancer ... help treat their cancer, writes Jonathan Waxman, Professor of Oncology ... the use of many of these approaches is obtuse – ...
... study on schizophrenic patients has come up with a finding ... anti-psychotic drugs. // ,The study was conducted upon ... the treatment they were getting was ineffective. They were then ... on new. Experienced doctors decided which type of anti–psychotic drug ...
... examination of 4 cases of botulism following cosmetic injections ... highly concentrated, //unlicensed preparation that resulted in toxin levels ... according to a report. ,Botulism is a rare ... bacterium Clostridium botulinum and toxin-producing strains of Clostridium baratii ...
... in on cardiac master cells that could develop into ... groups of researchers who have been putting their independent ... teams from Massachusetts General Hospital have recognized a variety ... this could develop into cardiac muscle, endothelial cells or ...
Cached Medicine News:Health News:Sleep Problems in Overweight Children Appear Fairly Common 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 3Health News:Protect Patients from Exploitation by Alternative Medicines Industry, Says Expert 2Health News:Old Anti-psychotic Drugs Are Equally Good 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: